Focus Partners Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109M Sell
315,585
-44,451
-12% -$15.2M 0.11% 177
2026
Q1
$122M Sell
360,036
-6,319
-2% -$2.25M 0.14% 158
2025
Q4
$114M Buy
366,355
+138,334
+61% +$43.9M 0.13% 159
2025
Q3
$64.3M Buy
228,021
+8,839
+4% +$2.56M 0.1% 171
2025
Q2
$61.2M Sell
219,182
-2,306
-1% -$653K 0.13% 158
2025
Q1
$69M Buy
221,488
+30,201
+16% +$8.92M 0.17% 128
2024
Q4
$49.9M Buy
191,287
+94,403
+97% +$28M 0.13% 162
2024
Q3
$31.2M Sell
96,884
-16,646
-15% -$5.45M 0.1% 201
2024
Q2
$35.5M Buy
113,530
+7,852
+7% +$2.31M 0.12% 169
2024
Q1
$30M Buy
105,678
+78,274
+286% +$22.9M 0.24% 106
2023
Q4
$7.89M Buy
+27,404
New +$7.47M 0.1% 176

Other funds holding AMGN

Focus Partners Wealth's AMGN Position: Q2 2026 in Review

Focus Partners Wealth reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $15.2M and leaving 315,585 shares worth $109M. The position accounts for 0.11% of the portfolio, ranked #177.

Focus Partners Wealth first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $122M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Focus Partners Wealth held 315,585 shares of Amgen worth $109M as of Q2 2026.
  • Focus Partners Wealth sold 44,451 Amgen shares in Q2 2026, an estimated $15.2M.
  • Amgen made up 0.11% of Focus Partners Wealth's portfolio in Q2 2026, its #177 holding.
  • Focus Partners Wealth first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Amgen position peaked at $122M in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.